Changes in the legal status of drugs from prescription only to non-prescription supply: implications for patients, pharmacists and public health
- At: 2004 FIP Congress in New Orleans (USA)
- Type: Presentation
- By: WALKER, Roger (National Public Health Service for Wales, National Public Health Service, Pontypool, United Kingdom)
- Co-author(s): Popovich (University of Illinois at Chicago, United States of America)
Over the past ten years there have been more than 170 applications in the UK to reclassify medicines from prescription only to non-prescription (pharmacy only or general sales list) status. This paper will review the implications of this for the patient, the pharmacist, and public health. Patient: the increased availability of medicines without.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.